<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Medicine : Signs and Symptoms: Dehydration (Medicine) Prevalence of chronic" exact="chikungunya" post="and associated risks factors in the French West Indies"/>
 <result pre="Indies (La Martinique): A prospective cohort study Prevalence of chronic" exact="chikungunya" post="and associated risks factors http://orcid.org/0000-0003-3962-8869BertolottiAntoineFormal analysisMethodologyProject administrationWriting – original"/>
 <result pre="the original author and source are credited.pntd.0007327.pdf Abstract Background The" exact="chikungunya" post="virus (CHIKV) is a re-emerging alphavirus that can cause"/>
 <result pre="chronic and potentially incapacitating rheumatic musculoskeletal disorders known as chronic" exact="chikungunya" post="arthritis (CCA). We conducted a prospective cohort study of"/>
 <result pre="and potentially incapacitating rheumatic musculoskeletal disorders known as chronic chikungunya" exact="arthritis" post="(CCA). We conducted a prospective cohort study of CHIKV-infected"/>
 <result pre="a prospective cohort study of CHIKV-infected subjects during the 2013" exact="chikungunya" post="outbreak in Martinique. The aim of this study was"/>
 <result pre="95%CI, 2.8; 30.7, p = 0.02) and at least one" exact="tenosynovitis" post="(RD 16.8, 95% CI, 1.4–32.2, p = 0.04). Conclusions"/>
 <result pre="Martinique confirms that CCA is a common complication of acute" exact="chikungunya" post="disease. Our analysis emphasized the importance of age and"/>
 <result pre="and adequate hydration were found to reduce the risk chronic" exact="chikungunya" post="disorders. Trial registration clinicaltrials.gov (NCT01099852). Author summary Chikungunya is"/>
 <result pre="chronic rheumatism. This suggests that, in the context of a" exact="chikungunya" post="epidemic, patients should drink plenty of fluids as soon"/>
 <result pre="[24], and in rare cases by severe manifestations such as" exact="encephalopathy" post="[21,24], acute hepatitis [25,26], myocarditis [27–29], and multi-organ failure."/>
 <result pre="rare cases by severe manifestations such as encephalopathy [21,24], acute" exact="hepatitis" post="[25,26], myocarditis [27–29], and multi-organ failure. The acute phase"/>
 <result pre="by severe manifestations such as encephalopathy [21,24], acute hepatitis [25,26]," exact="myocarditis" post="[27–29], and multi-organ failure. The acute phase (viremic period)"/>
 <result pre="the World Health Organization [30] defined a person with chronic" exact="chikungunya" post="as a &quot;person with previous clinical diagnosis of chikungunya"/>
 <result pre="chronic chikungunya as a &quot;person with previous clinical diagnosis of" exact="chikungunya" post="after 12 weeks of the onset of the symptoms"/>
 <result pre="or edema, continuously or recurrently.�? Chronic arthralgia (i.e., &quot;suspected chronic" exact="chikungunya" post="arthritis�? or &quot;CCA�?) is a common complication post CHIKV-infection."/>
 <result pre="have reported that 40 to 60% of patients with acute" exact="chikungunya" post="experience significantly impaired quality of life in the long"/>
 <result pre="in the French West Indies. The first autochthonous cases of" exact="chikungunya" post="were described in the region in November 2013 (in"/>
 <result pre="the inclusion criteria of the DAG study were extended to" exact="chikungunya" post="cases, and the protocol was adjusted accordingly (namely by"/>
 <result pre="by including a broad description of rheumatic disorders specific to" exact="chikungunya" post="disease). In May 2014, the &quot;DAG�? study became the"/>
 <result pre="cohort composed of 2 groups: the dengue group and the" exact="chikungunya" post="group. This study is registered on clinicaltrials.gov (NCT01099852). The"/>
 <result pre="the beginning of the epidemic, the medical team of the" exact="infectious disease" post="department was trained by a group of rheumatologists, one"/>
 <result pre="stiffness, arthritis, enthesitis, joint pain, etc.), and an assessment of" exact="peripheral neuropathy" post="with the douleur neuropathique 4 (DN4, neuropathic pain 4)"/>
 <result pre="arthritis, enthesitis, joint pain, etc.), and an assessment of peripheral" exact="neuropathy" post="with the douleur neuropathique 4 (DN4, neuropathic pain 4)"/>
 <result pre="to these patients. Only patients who felt completely recovered from" exact="chikungunya" post="at all visits from M3 onwards were categorized as"/>
 <result pre="from M3 onwards were categorized as NO CCA (without chronic" exact="chikungunya" post="disease). The global clinical assessment of CCA subjects was"/>
 <result pre="conducted using the &quot;Multi-Dimensional Health Assessment Questionnaire�? (MDHAQ). Patients with" exact="chikungunya" post="are known to experience a fluctuation of their symptoms"/>
 <result pre="period of follow-up allowed for the comprehensive description of chronic" exact="chikungunya" post="disorders and for patients to characterize the time point"/>
 <result pre="from M3 onwards; &quot;death�?: dead patients; &quot;CCA�?: patients with chronic" exact="chikungunya" post="arthritis; &quot;no CCA�?: patients without chronic chikungunya arthritis. Overall"/>
 <result pre="patients with chronic chikungunya arthritis; &quot;no CCA�?: patients without chronic" exact="chikungunya" post="arthritis. Overall prevalence of CCA at 12 months Of"/>
 <result pre="patients, 94.52%) with joint pain (90.41%), swelling (42.46%), stiffness (27.40%)," exact="arthritis" post="(20.55%), tenosynovitis (13.70%), and enthesitis (10.96%). The most affected"/>
 <result pre="with joint pain (90.41%), swelling (42.46%), stiffness (27.40%), arthritis (20.55%)," exact="tenosynovitis" post="(13.70%), and enthesitis (10.96%). The most affected joints were"/>
 <result pre="bed 94 24 (55.81) 36 (70.59) 14.77 [-4.63;34.18] 0.1* Non-palmoplantar" exact="rash" post="94 26 (60.47) 29 (56.86) -3.6 [-23.56;16.36] 0.7* Vertigo"/>
 <result pre="pain 73 6 (16.22) 10 (27.78) 11.56 [-7.28;30.41] 0.2** Peripheral" exact="neuropathy" post="46 6 (23.08) 3 (15.00) -8.08 [-30.60;14.44] 0.5** Confusional"/>
 <result pre="1** Menorrhagia 167 1 (1.25) 0 -1.25 [-3.68;1.18] 0.5** Petechial" exact="purpura" post="167 0 1 (1.15) 1.15 [-1.09;3.39] 1** Pleural effusion"/>
 <result pre="2 (2.50) 5 (5.75) 3.25 [-2.72;9.22] 0.3** Thrombopathy or chronic" exact="thrombocytopenia" post="167 1 (1.25) 6 (6.90) 5.65 [-0.21;11.50] 0.07** Asthma"/>
 <result pre="HCV 167 0 0 Rheumatoid polyarthritis 167 0 0 Arthropathic" exact="psoriasis" post="167 0 0 Psoriasis 167 0 0 TREATMENTS Analgesic"/>
 <result pre="+ Western Europe + India; HIV: human immunodeficiency virus; HBV:" exact="hepatitis" post="B virus; HCV: hepatitis C virus; DN4: douleur neuropathique"/>
 <result pre="India; HIV: human immunodeficiency virus; HBV: hepatitis B virus; HCV:" exact="hepatitis" post="C virus; DN4: douleur neuropathique 4/neuropathic pain 4; EQ-5D:"/>
 <result pre="DN4: douleur neuropathique 4/neuropathic pain 4; EQ-5D: EuroQol-5 dimension; APS:" exact="antiphospholipid syndrome;" post="BMI: body mass index; SBP: systolic blood pressure; DBP:"/>
 <result pre="16.7, 95%CI, 2.8;30.7, p = 0.02) and at least one" exact="tenosynovitis" post="(RD 16.8, 95% CI, 1.4–32.2, p = 0.04) (Table"/>
 <result pre="Fig 2 Loess curve between age and prevalence of chronic" exact="chikungunya" post="according to sex. Pink corresponds to female sex and"/>
 <result pre="33 (89.2) 33 (91.7) 2.5 [-11.0;16.0] 0.7 Joint swelling without" exact="arthritis" post="73 17 (46.0) 14 (38.9) -7.1 [-29.7;15.6] 0.5 Joint"/>
 <result pre="73 1 (2.7) 7 (19.4) 16.7 [2.8;30.7] 0.02 Arthritis with" exact="synovitis" post="73 1 (2.7) 0 -2.7 [-7.9;2.5] 0.3 Periostitis 73"/>
 <result pre="being the most common chronic symptoms (Table 3). Enthesitis (13%)," exact="arthritis" post="(7.4%), and tenosynovitis (5.6%) were less frequently observed. Ankles"/>
 <result pre="common chronic symptoms (Table 3). Enthesitis (13%), arthritis (7.4%), and" exact="tenosynovitis" post="(5.6%) were less frequently observed. Ankles (31.5%) and knees"/>
 <result pre="(22.2%) were less frequently involved. A quarter of patients presented" exact="peripheral neuropathy" post="(27.7%), and 10 out of 30 patients had a"/>
 <result pre="were less frequently involved. A quarter of patients presented peripheral" exact="neuropathy" post="(27.7%), and 10 out of 30 patients had a"/>
 <result pre="7 0–32 Joint pain 54 47 (87.04) Joint swelling without" exact="arthritis" post="54 12 (22.00) Joint stiffness 54 18 (33.33) Arthritis"/>
 <result pre="Tenosynovitis 54 3 (5.56) Enthesitis 54 7 (12.96) Arthritis with" exact="synovitis" post="54 1 (1.85) Periostitis 54 1 (1.85) Peripheral neuropathy"/>
 <result pre="with synovitis 54 1 (1.85) Periostitis 54 1 (1.85) Peripheral" exact="neuropathy" post="47 13 (27.66) DN4 score mean value in the"/>
 <result pre="in Martinique during the 2013-outbreak. The overall prevalence of chronic" exact="chikungunya" post="in our cohort was 52.10% (CI 95% 44.50–59.70), which"/>
 <result pre="were shown to be the main risk factors for chronic" exact="chikungunya" post="disease [6,32,34,40,41,48,49]. Some studies focusing on gender have suggested"/>
 <result pre="association between CCA and pre-existing diseases—whether rheumatic disorders [48] like" exact="osteoarthritis" post="[64] and rheumatoid arthritis [65–69] or cardiovascular diseases like"/>
 <result pre="and pre-existing diseases—whether rheumatic disorders [48] like osteoarthritis [64] and" exact="rheumatoid arthritis" post="[65–69] or cardiovascular diseases like hypertension [70] and diabetes"/>
 <result pre="pre-existing diseases—whether rheumatic disorders [48] like osteoarthritis [64] and rheumatoid" exact="arthritis" post="[65–69] or cardiovascular diseases like hypertension [70] and diabetes"/>
 <result pre="and autoimmune processes in the acute and chronic phases of" exact="chikungunya" post="disease [62,71]. Several of them have identified a positive"/>
 <result pre="as was the case in previous studies [38,72–74], enthesitis and" exact="tenosynovitis" post="were observed in our cohort. One study reported relapsing"/>
 <result pre="the development of CCA was associated with at least 1" exact="tenosynovitis" post="or 1 enthesitis in the acute phase. These 2"/>
 <result pre="and psychiatric and psychological evaluation [81,82–85]. Long-term disabilities caused by" exact="chikungunya" post="are costly at the individual and collective scales. The"/>
 <result pre="individual and collective scales. The economic impact of the 2005–2006" exact="chikungunya" post="outbreak in Reunion Island was estimated at 51.63 million"/>
 <result pre="investigations. To conclude, this first prospective study conducted during the" exact="chikungunya" post="outbreak in Martinique has described the course of the"/>
 <result pre="4DelatteH, PaupyC, DehecqJS, ThiriaJ, FaillouxAB, FontenilleD. [Aedes albopictus, vector of" exact="chikungunya" post="and dengue viruses in Reunion Island: biology and control].Parasite"/>
 <result pre="and rheumatoid-like polyarthritis more than 2 years after infection with" exact="chikungunya" post="virus.Postgrad Med J.2013; 89(1054): 440–7. 10.1136/postgradmedj-2012-13147723645664 7Ngwe TunMM, InoueS,"/>
 <result pre="InoueS, ThantKZ, TalemaitogaN, AryatiA, DimaanoEM, et al.Retrospective seroepidemiological study of" exact="chikungunya" post="infection in South Asia, Southeast Asia and the Pacific"/>
 <result pre="10.1016/j.actatropica.2017.06.02628690146 11RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliA, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
 <result pre="13SourisseauM, SchilteC, CasartelliN, TrouilletC, Guivel-BenhassineF, RudnickaD, et al.Characterization of reemerging" exact="chikungunya" post="virus.PLoS Pathog.2007; 3(6): e8910.1371/journal.ppat.003008917604450 14HiggsS, ZieglerSA. A nonhuman primate"/>
 <result pre="Pathog.2007; 3(6): e8910.1371/journal.ppat.003008917604450 14HiggsS, ZieglerSA. A nonhuman primate model of" exact="chikungunya" post="disease. J Clin Invest. 2010; 120(3): 657–60. 10.1172/JCI4239220179348 15Jaffar-BandjeeMC,"/>
 <result pre="Invest. 2010; 120(3): 657–60. 10.1172/JCI4239220179348 15Jaffar-BandjeeMC, GasqueP. [Physiopathology of chronic" exact="arthritis" post="following chikungunya infection in man].Médecine Trop Rev Corps Santé"/>
 <result pre="120(3): 657–60. 10.1172/JCI4239220179348 15Jaffar-BandjeeMC, GasqueP. [Physiopathology of chronic arthritis following" exact="chikungunya" post="infection in man].Médecine Trop Rev Corps Santé Colon.2012; 72"/>
 <result pre="57(2): 177–80. 10.4103/0028-3886.5128919439849 20BankAM, BatraA, ColoradoRA, LyonsJL. Myeloradiculopathy associated with" exact="chikungunya" post="virus infection. J Neurovirol. 2016; 22(1): 125–8. 10.1007/s13365-015-0372-926306687 21GérardinP,"/>
 <result pre="Southern Province, Tanganyika Territory, in 1952–53; an additional note on" exact="chikungunya" post="virus isolations and serum antibodies. Trans R Soc Trop"/>
 <result pre="BrigantiE, ZanottiM, ZauliT, NicolettiL, MaguranoF, et al.A fatal case of" exact="encephalitis" post="associated with Chikungunya virus infection. Scand J Infect Dis."/>
 <result pre="10.1080/0036554080241905518819040 26LemantJ, BoissonV, WinerA, ThibaultL, AndréH, TixierF, et al.Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the Reunion Island"/>
 <result pre="PauleP, OliverM. Chikungunya virus-induced myopericarditis: toward an increase of dilated" exact="cardiomyopathy" post="in countries with epidemics?Am J Trop Med Hyg. 2008;"/>
 <result pre="2008; 78(2): 212–3. 18256416 29MaitiCR, MukherjeeAK, BoseB, SahaGL. Myopericarditis following" exact="chikungunya" post="virus infection.J Indian Med Assoc. 1978; 70(11): 256–8. 712084"/>
 <result pre="712084 30LemantJ, BoissonV, WinerA, ThibaultL, AndréH, TixierF, et al.Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the Reunion Island"/>
 <result pre="MuraM, LéonL, VirionJ-M, LetortM-J, et al.Impaired quality of life after" exact="chikungunya" post="virus infection: a 2-year follow-up study.Rheumatol Oxf Engl. 2012;"/>
 <result pre="SimonF. Morbidity and impaired quality of life 30 months after" exact="chikungunya" post="infection: comparative cohort of infected and uninfected French military"/>
 <result pre="212–9. 10.1097/MD.0b013e318260b60422732952 39MoroML, GrilliE, CorvettaA, SilviG, AngeliniR, MascellaF, et al.Long-term" exact="chikungunya" post="infection clinical manifestations after an outbreak in Italy: a"/>
 <result pre="SimonF, DeparisX, MarimoutouC. Identification of initial severity determinants to predict" exact="arthritis" post="after chikungunya infection in a cohort of French gendarmes.BMC"/>
 <result pre="MarimoutouC. Identification of initial severity determinants to predict arthritis after" exact="chikungunya" post="infection in a cohort of French gendarmes.BMC Musculoskelet Disord."/>
 <result pre="43LedransM, NajioullahF, CesaireR, Locatelli JouansC, VincentJ, DaudensE, et al.Émergence du" exact="chikungunya" post="dans les départements français d’Amérique: organisation et résultats de"/>
 <result pre="de LamballerieX, SalezN, PiorkowskiG, RichardP, PaturelL, et al.Prospective detection of" exact="chikungunya" post="virus in blood donors, Caribbean 2014. Blood. 2014; 123(23):"/>
 <result pre="RochaJ, et al.Fluid intake and decreased risk for hospitalization for" exact="dengue fever," post="Nicaragua. Emerg Infect Dis.2003; 9(8): 1003–6. 10.3201/eid0908.02045612967502 55NasirNH, MohamadM,"/>
 <result pre="2016; 29:180–7. 10.1016/j.actbio.2015.09.03426432435 61LokireddyS, VemulaS, VaddeR. Connective tissue metabolism in" exact="chikungunya" post="patients. Virol J. 2008; 5: 3110.1186/1743-422X-5-3118302795 62HoarauJ-J, BandjeeM-CJ, TrototPK,"/>
 <result pre="3(3): e38910.1371/journal.pntd.000038919274071 65BouquillardÉ, CombeB. A report of 21 cases of" exact="rheumatoid arthritis" post="following Chikungunya fever. A mean follow-up of two years."/>
 <result pre="e38910.1371/journal.pntd.000038919274071 65BouquillardÉ, CombeB. A report of 21 cases of rheumatoid" exact="arthritis" post="following Chikungunya fever. A mean follow-up of two years."/>
 <result pre="Aw-YeangH-X, FoxJM, TaffnerS, MalkovaON, OhST, et al.Brief Report: Chikungunya viral" exact="arthritis" post="in the United States: A mimic of seronegative rheumatoid"/>
 <result pre="10.4049/jimmunol.090418120404274 72ChaaithanyaIK, MuruganandamN, RaghurajU, SugunanAP, RajeshR, AnweshM, et al.Chronic inflammatory" exact="arthritis" post="with persisting bony erosions in patients following chikungunya infection."/>
 <result pre="al.Chronic inflammatory arthritis with persisting bony erosions in patients following" exact="chikungunya" post="infection. Indian J Med Res. 2014; 140(1): 142–5. 25222790"/>
 <result pre="Mar 28] [Internet]. Available from: http://www.ars.martinique.sante.fr/fileadmin/MARTINIQUE/Votre_Sante/Veille_sanitaire/Les_champs_de_competences/Chikungunya/Telecharger/Chik_Fiche_info_medecin_-_V1_Dec_2013.pdf 79Prise en charge du" exact="chikungunya" post="subaigu et chronique. Fiche de synthèse. 2014 Oct 17"/>
 <result pre="SimonF, DeparisX, MarimoutouC. Identification of initial severity determinants to predict" exact="arthritis" post="after chikungunya infection in a cohort of French gendarmes.BMC"/>
 <result pre="MarimoutouC. Identification of initial severity determinants to predict arthritis after" exact="chikungunya" post="infection in a cohort of French gendarmes.BMC Musculoskelet Disord."/>
</results>
